The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer

Despite the use of front-line anticancer drugs such as paclitaxel for ovarian cancer treatment, mortality rates have remained almost unchanged for the past three decades and the majority of patients will develop recurrent chemoresistant disease which remains largely untreatable. Overcoming chemoresi...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Bates, Mark, Spillane, Cathy D., Gallagher, Michael F., McCann, Amanda, Martin, Cara, Blackshields, Gordon, Keegan, Helen, Gubbins, Luke, Brooks, Robert, Brooks, Doug, Selemidis, Stavros, O’Toole, Sharon, O’Leary, John J.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769460/
https://ncbi.nlm.nih.gov/pubmed/33370338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243715
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料